Healthcare -
Biotechnology - NASDAQ - US
$ 35.01
-4.66 %
$ 3.21 B
Market Cap
-18.23
P/E
Price Target
Average
139.71%
Revenue Forecast
Estimate
108.31%
EBIT
Estimate
--80.34%
Net Income
Estimate
38.12%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Legend Biotech Corporation
Wall Street analysts predict an average 1-year price target for LEGN of $83.9 , with forecasts ranging from
a
low of
$60 to a high of $94 .
LEGN Lowest Price Target
Wall Street Target
60 USD
71.38%
LEGN Average Price Target
Wall Street Target
83.9 USD
139.71%
LEGN Highest Price Target
Wall Street Target
94 USD
168.49%
REVENUE FORECAST
Revenue Forecast Chart LEGN
EBIT FORECAST
EBIT Forecast Chart LEGN
NET INCOME FORECAST
Net Income Chart LEGN